SCHEMBL18669088

SCHEMBL18669088

O=c1[nH]cnc2ccc(NCc3c(Cl)cccc3Cl)cc12

nearest known ligand 0.69

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 7/20 0.69
PARP1 P09874 9/20 0.54
IP6K3 Q96PC2 3/20 0.47
IP6K2 Q9UHH9 3/20 0.47
DHFR P00374 1/20 0.47
PIM1 P11309 2/20 0.47
AURKA O14965 1/20 0.47
DAPK3 O43293 1/20 0.47
JAK2 O60674 1/20 0.47
PRKD3 O94806 1/20 0.47
MAP4K4 O95819 1/20 0.47
PAK4 O96013 1/20 0.47
ABL1 P00519 1/20 0.47
CSF1R P07333 1/20 0.47
RET P07949 1/20 0.47
IGF1R P08069 1/20 0.47
MET P08581 1/20 0.47
PDGFRB P09619 1/20 0.47
FGFR1 P11362 1/20 0.47
PDGFRA P16234 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22387755 0.82 IP6K1 (1.00) IP6K1PARP1IP6K3IP6K2DHFR
SCHEMBL18669149 0.79 QPCT (0.44) IP6K1PARP1ABL1ALDH1A1
SCHEMBL14550820 0.77 IP6K1 (0.77) IP6K1PARP1IP6K3IP6K2DHFR
SCHEMBL18687959 0.76 JAK2 (0.47) IP6K1PARP1JAK2CHEK1ALDH1A1
SCHEMBL17315551 0.76 IP6K1 (0.64) IP6K1PARP1IP6K3IP6K2DHFR
SCHEMBL6886187 0.73 PARP1 (0.63) IP6K1PARP1IP6K3IP6K2PIM1
SCHEMBL18669065 0.72 NPC1 (0.49) ABL1ALDH1A1
SCHEMBL29784205 0.71 PARP1 (1.00) IP6K1PARP1IP6K3IP6K2PIM1
SCHEMBL2191006 0.71 PARP1 (1.00) IP6K1PARP1IP6K3IP6K2PIM1
SCHEMBL7804830 0.71 DHFR (0.58) IP6K1PARP1DHFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 WO disclosed
WO-2017049409-A1 COMPOSITIONS FOR PROMOTING READTHROUGH OF PREMATURE TERMINATION CODONS, AND METHODS OF USING THE SAME THE CENTRE FOR DRUG RESEARCH AND DEVELOPMENT (CA) 2017-03-30 WO disclosed